Ann: Quarterly Report and Appendix 4C, page-50

I guess The Management has already mentioned in the AGM presentation:

Just recap the following:

1) The costs associated with conducting the trial will depend on the final approved design...
2) The major costs associated with the conduct of the trial are not anticipated to come through until later in 2021.
3) The Company would advise the market should these corporate interactions (partnering, corporate management)lead to a material transaction

So, if everything in place, I believe the management will make the announcement when the time is right.

It's just a bit of a waiting game at the moment...be patient...